Medicare Enrolled
Dr. Carlos Ramirez-Mejia, MD
Neurology · Miami, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ramirez-Mejia from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ramirez-Mejia? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ramirez-Mejia
Dr. Carlos Ramirez-Mejia is a neurology in Miami, FL, with 19 years in practice. Based on federal Medicare data, Dr. Ramirez-Mejia performed 949 Medicare services across 752 unique beneficiaries.
Between the years covered by Open Payments, Dr. Ramirez-Mejia received a total of $24,448 from 89 pharmaceutical and/or device companies across 1009 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ramirez-Mejia is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 32% volume in FL$ $24,448 industry payments
Medicare Practice Summary
Medicare Utilization ↗949
Medicare services
Top 32% in FL for neurology
752
Unique beneficiaries
$127
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~50 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 252 | $100 | $562 |
| EEG, extended monitoring | 109 | $365 | $1,914 |
| Administration of psychological or neuropsychological test by technician, each additional 30 minutes | 93 | $29 | $155 |
| Office visit, established patient, complex (40-54 min) | 71 | $146 | $788 |
| Annual depression screening | 52 | $19 | $77 |
| New patient office visit, complex (60-74 min) | 44 | $189 | $976 |
| New patient office visit (45-59 min) | 40 | $135 | $730 |
| Ultrasound of both sides of head and neck blood flow | 37 | $156 | $1,037 |
| Needle measurement of electrical activity in arm or leg muscles, complete study | 34 | $81 | $433 |
| Evaluation of neuropsychological test, first hour | 31 | $108 | $560 |
| Evaluation of neuropsychological test, each additional hour | 31 | $81 | $433 |
| Administration of psychological or neuropsychological test by technician, first 30 minutes | 31 | $28 | $156 |
| Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | 21 | $37 | $615 |
| Ultrasound of within the brain blood flow | 20 | $106 | $940 |
| Sleep study in sleep lab (6 years or older) | 18 | $212 | $2,614 |
| Evaluation and testing for balance with recording | 17 | $85 | $465 |
| Test to assess balance during warm and cool irrigation in both ears | 16 | $33 | $177 |
| Evaluation of brain response to sound for determination of hearing threshold with interpretation and report | 16 | $89 | $505 |
| Nerve conduction, 9-10 studies | 16 | $174 | $960 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$24,448
Total received (2018-2024)
Avg $3,493/year across 7 years
Top 13% in FL for neurology
89
Companies
1,009
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$24,292 (99.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$156 (0.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$5,595
2023$4,775
2022$3,516
2021$1,834
2020$1,564
2019$3,333
2018$3,831
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$3,247
Teva Pharmaceuticals USA, Inc.
$1,819
Amgen Inc.
$1,616
UCB, Inc.
$1,316
Lilly USA, LLC
$920
PFIZER INC.
$850
Allergan Inc.
$788
Alexion Pharmaceuticals, Inc.
$720
Novartis Pharmaceuticals Corporation
$718
Neurelis, Inc.
$601
Lundbeck LLC
$576
ACADIA Pharmaceuticals Inc
$512
Assertio Therapeutics, Inc.
$509
Biogen, Inc.
$507
GENZYME CORPORATION
$450
Sunovion Pharmaceuticals Inc.
$432
Supernus Pharmaceuticals, Inc.
$424
Eisai Inc.
$388
Allergan, Inc.
$377
Scilex Pharmaceuticals Inc.
$362
Neurocrine Biosciences, Inc.
$357
Kyowa Kirin, Inc.
$356
SK Life Science, Inc.
$333
SCILEX PHARMACEUTICALS INC.
$292
Biohaven Pharmaceutical Holding Company Ltd.
$265
Otsuka America Pharmaceutical, Inc.
$263
US WorldMeds, LLC
$249
AbbVie Inc.
$241
Acorda Therapeutics, Inc
$227
Avanir Pharmaceuticals, Inc.
$216
MDD US Operations, LLC
$204
Alnylam Pharmaceuticals Inc.
$194
Egalet US Inc
$188
Merz Pharmaceuticals, LLC
$186
EMD Serono, Inc.
$180
ARGENX US, INC.
$172
Adamas Pharmaceuticals, Inc.
$170
HARMONY BIOSCIENCES LLC
$165
Azurity Pharmaceuticals, Inc.
$158
Promius Pharma LLC
$151
Boston Scientific Corporation
$146
Amneal Pharmaceuticals LLC
$144
IDORSIA PHARMACEUTICALS US INC
$136
CSL Behring
$136
MITSUBISHI TANABE PHARMA AMERICA, INC.
$128
Akcea Therapeutics, Inc.
$121
GE HEALTHCARE
$105
Harmony Biosciences Llc
$95
Biohaven Pharmaceuticals, Inc.
$93
Corium, LLC
$93
Upsher-Smith Laboratories LLC
$80
Harmony Biosciences LLC
$80
AstraZeneca Pharmaceuticals LP
$80
Averitas Pharma Inc.
$72
Vertical Pharmaceuticals, LLC
$63
Alfasigma USA, Inc.
$61
Avion Pharmaceuticals
$60
LivaNova USA, Inc.
$59
Almatica Pharma LLC
$57
Bayer HealthCare Pharmaceuticals Inc.
$54
Impax Laboratories, Inc.
$53
Aprecia Pharmaceuticals, LLC
$50
Inspire Medical Systems, Inc.
$49
Piramal Imaging Limited
$47
Mitsubishi Tanabe Pharma America, Inc.
$45
EISAI INC.
$45
Takeda Pharmaceuticals U.S.A., Inc.
$45
Grifols USA, LLC
$45
Sumitomo Pharma America, Inc.
$42
Genentech USA, Inc.
$39
Shire North American Group Inc
$38
CATALYST PHARMACEUTICALS, INC.
$35
Zyla Life Sciences, Inc.
$34
Zyla Life Sciences
$31
TerSera Therapeutics LLC
$31
GE HealthCare
$28
UPSHER-SMITH LABORATORIES LLC
$24
AQUESTIVE THERAPEUTICS, INC.
$23
REVANCE THERAPEUTICS, INC.
$22
Arbor Pharmaceuticals, Inc.
$20
Mallinckrodt LLC
$18
ARBOR PHARMACEUTICALS, INC.
$18
BANNER LIFE SCIENCES, LLC
$17
Ipsen Biopharmaceuticals, Inc
$16
ASSERTIO THERAPEUTICS, INC.
$15
Currax Pharmaceuticals LLC
$14
ASSERTIO THERAPEUTICS, Inc.
$14
Life Molecular Imaging Ltd
$14
Nevro Corp.
$13
Top 3 companies account for 27.3% of total payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · Adlarity · Aimovig · Apokyn · Austedo XR · Azstarys · BAFIERTAM · BOTOX · BOTOX THERAPEUTIC · Betaseron · Briviact · CAMBIA · COMIRNATY · CONTRAVE · COPAXONE · Cambia · DAXXIFY · Dhivy · Dysport · EMGALITY · ERGOMAR · FIRDAPSE · Fintepla · Fycompa · GAMMAGARD · GILENYA · GOCOVRI · GRALISE · Gamunex-C · Gralise · HORIZANT · Hizentra · Horizant · INBRIJA · INGREZZA · INSPIRE · KESIMPTA · KYNMOBI · LEMTRADA · LOREEV XR · LORZONE · LYRICA · Leqembi · MAVENCLAD · MYOBLOC · Mavenclad · NAMZARIC · NAPRELAN · NATRELLE SALINE-FILLED BREAST IMPLANTS · NEURACEQ · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nourianz · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS · ONPATTRO · OSMOLEX ER · OXTELLAR XR · Ocrevus · Ongentys · PANZYGA · PAXLOVID · POMPE - DISEASE · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUTENZA · QUVIVIQ · RADICAVA · REXULTI · RYTARY · Radicava · Rebif · Repatha · Rystiggo · SOLIRIS · SPRIX · SYMPAZAN · Senza · Soliris · Spritam · TECFIDERA · TEGSEDI · TOPIRAMATE Extended Release Capsules · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · UBRELVY · ULTOMIRIS · VALTOCO · VIIBRYD · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VUMERITY · VYALEV · VYEPTI · VYVANSE · VYVGART · VYVGART HYTRULO · Vimpat · WAINUA · WAKIX · WATCHMAN · XCOPRI · Xadago · Xeomin · ZAVZPRET · ZEMBRACE SYMTOUCH · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zembrace
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $2,576 per 100 Medicare services performed
Geographic Context
Neurologys within 10 mi
220
Per 100K population
8.2
County median income
$68,694
Nearest hospital
BAPTIST HOSPITAL OF MIAMI
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Ramirez-Mejia is a clinical cardiology specialist, with moderate Medicare volume, and high industry engagement (low-engagement, top 13%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Ramirez-Mejia experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Ramirez-Mejia performed 252 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ramirez-Mejia receive payments from pharmaceutical companies?
Yes. Dr. Ramirez-Mejia received a total of $24,448 from 89 companies across 1,009 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ramirez-Mejia's costs compare to other neurologys in Miami?
Dr. Ramirez-Mejia's average Medicare payment per service is $127. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ramirez-Mejia) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologys in Miami
Browse neurologys in Miami ranked by procedure volume and transparency data.
Highest volume
Top Neurologys in FL
Neurologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologys in FL
Which FL neurologys receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC..
By company
Teva Pharmaceuticals USA, Inc. Payments to Doctors
See all physicians who received payments from Teva Pharmaceuticals USA, Inc..
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology